PH18970A - Compostions for treating glaucoma - Google Patents

Compostions for treating glaucoma

Info

Publication number
PH18970A
PH18970A PH27416A PH27416A PH18970A PH 18970 A PH18970 A PH 18970A PH 27416 A PH27416 A PH 27416A PH 27416 A PH27416 A PH 27416A PH 18970 A PH18970 A PH 18970A
Authority
PH
Philippines
Prior art keywords
alkenyl
lower alkyl
alkynyl
hydroxyloweralkyl
aralkyl
Prior art date
Application number
PH27416A
Other languages
English (en)
Inventor
William Lesley Matier
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of PH18970A publication Critical patent/PH18970A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH27416A 1981-06-23 1982-06-14 Compostions for treating glaucoma PH18970A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,658 US4454154A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (1)

Publication Number Publication Date
PH18970A true PH18970A (en) 1985-11-26

Family

ID=23057573

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27416A PH18970A (en) 1981-06-23 1982-06-14 Compostions for treating glaucoma

Country Status (17)

Country Link
US (1) US4454154A (sv)
EP (1) EP0082873B1 (sv)
JP (1) JPH0653663B2 (sv)
AU (1) AU565752B2 (sv)
CA (1) CA1188224A (sv)
CH (1) CH654205A5 (sv)
ES (1) ES8401928A1 (sv)
GB (1) GB2111387B (sv)
GR (1) GR76847B (sv)
IL (1) IL66070A (sv)
IT (1) IT1156058B (sv)
NL (1) NL8220252A (sv)
NZ (1) NZ200972A (sv)
PH (1) PH18970A (sv)
SE (1) SE462075B (sv)
WO (1) WO1983000014A1 (sv)
ZA (1) ZA824340B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
DE1593762A1 (de) * 1967-02-06 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2048838A1 (de) * 1970-10-05 1972-04-06 C H Boehnnger Sohn, 6507 Ingel heim Neue 1 Phenoxy 2 hydroxy 3 hydroxyal kylaminopropane und Verfahren zu ihrer Her stellung
FR2132570B1 (sv) * 1971-04-09 1974-08-02 Lipha
JPS4875539A (sv) * 1972-01-12 1973-10-11
JPS49247A (sv) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
EP0003664B1 (en) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
JPS58500996A (ja) 1983-06-23
EP0082873A1 (en) 1983-07-06
SE8300913D0 (sv) 1983-02-18
AU8737482A (en) 1983-01-18
SE8300913L (sv) 1983-02-18
ES513387A0 (es) 1984-01-01
GB8303061D0 (en) 1983-03-09
EP0082873A4 (en) 1983-11-11
GB2111387B (en) 1986-02-05
GR76847B (sv) 1984-09-04
ZA824340B (en) 1983-04-27
NL8220252A (nl) 1983-05-02
CA1188224A (en) 1985-06-04
NZ200972A (en) 1986-10-08
JPH0653663B2 (ja) 1994-07-20
IL66070A (en) 1987-03-31
CH654205A5 (de) 1986-02-14
US4454154A (en) 1984-06-12
IL66070A0 (en) 1982-09-30
IT1156058B (it) 1987-01-28
WO1983000014A1 (en) 1983-01-06
GB2111387A (en) 1983-07-06
ES8401928A1 (es) 1984-01-01
EP0082873B1 (en) 1988-12-07
IT8267796A0 (it) 1982-06-22
SE462075B (sv) 1990-05-07
AU565752B2 (en) 1987-09-24

Similar Documents

Publication Publication Date Title
ES2042625T3 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
PH18970A (en) Compostions for treating glaucoma
ATE207360T1 (de) Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
BR8303197A (pt) Lente intraocular, corpo de lente e processo para inserir, em um olho, uma lente intraocular
CA2071629A1 (en) Use of insulin sensitizing agents to treat hypertension
AU695322B2 (en) Liposome eye drops
ES2071227T3 (es) Composicion para gotas para los ojos.
PT98089A (pt) Processo para a preparacao de composicoes contendo (+-)-cis-1-acetil-4-<4- 2-(2,4-diclorofenil)-2-(1h-imidazol-1-ilmetil)-1,3-dioxolan-4-il -metoxi -fenil>-piperazina(quetoconazole)para o tratamento de alopecia
FI911131A0 (sv) Förfarande för framställning av 3-arylkarbonyl-1-aminoalkyl-1H-indolföreningar med antiglaukomaeffekt
ES2080330T5 (es) Procedimiento para reducir el contenido residual en agente de alquilacion libre en soluciones acuosas de tensioactivos cationicos.
BR9709916A (pt) Processo para o tratamento de fibras de celulose e de conjuntos feitos destas fibras
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ATE132750T1 (de) Behandlung von intraokularem druck mit einer synergischen kombination
IT8521006A0 (it) Macchina per molare lenti oftalmiche, particolarmente per la delimitazione del contorno e/o la bisellatura o taglio di scanalatura di questa.
EP0304789A3 (en) Benzimidazole derivatives
ATE133337T1 (de) Behandlung des glaukoms mit synergistischer kombination
SE8300914D0 (sv) Kompositioner for behandling av glaukom
AR246958A1 (es) Procedimiento para preparar 1-hidroximetilpirazol.
IT8424240A0 (it) Posto di molatura per rettificatrice, particolarmente per la formazione di una smussatura o una scanalatura in una lente oftalmica.
IE872087L (en) Treating contact lenses
DK645489A (da) Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere
WO1998001099A3 (en) Method of treating retinal ischemia and glaucoma
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
JPS6448693A (en) Laser beam machine
SU1711227A1 (ru) Способ моделировани офтальмогипотензии